Gold Standard:Postoperative pathological diagnosis

5 trials

Sponsors

Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science Center, Fudan university Shanghai cancer center, Peking University First Hospital, Huashan Hospital, Fudan University, Qilu Hospital of Shandong University

Conditions

Endometrial cancerHigh-Grade GliomasLaryngeal Squamous Cell CarcinomaOvarian cancerUrothelial carcinoma

Early Phase 1

The clinical value of estrogen receptor ß5 expression in endometrial carcinogenesis

Active, not recruitingChiCTR2000035987

Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science CenterEndometrial cancer

Start: 2020-10-01Updated: 2020-08-31

Identification and clinical application of serum exocrine miRNA model in patients with CA125 negative high grade serous ovarian cancer

Active, not recruitingChiCTR2000037259

Fudan university Shanghai cancer centerOvarian cancer

Start: 2022-01-01Updated: 2020-10-13

Unknown Phase

Development, validation, and clinical application of a novel tumor marker based on urine DNA methylation for the non-invasive diagnosis of urinary for urothelial carcinoma

RecruitingChiCTR2200064162

Peking University First HospitalUrothelial carcinoma

Start: 2022-09-22Updated: 2023-04-17

Clinical Study of the CSF1R-Targeted Molecular Probe ¹¹C-CPPC for Imaging of High-Grade Gliomas

Active, not recruitingChiCTR2500102291

Huashan Hospital, Fudan UniversityHigh-Grade Gliomas

Start: 2025-05-16Updated: 2025-05-19

Predicting lymph node metastasis of laryngeal squamous cell carcinoma using CT radiomics and deep learning

Active, not recruitingChiCTR2600134112

Qilu Hospital of Shandong UniversityLaryngeal Squamous Cell Carcinoma

Start: 2025-04-03Updated: 2026-10-12